|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Novel concepts in radiation-induced cardiovascular disease显示文摘Radiation-induced cardiovascular disease(RICVD) is the most common nonmalignant cause of morbidity and mortality among cancer survivors who have undergone mediastinal radiation therapy(RT).Cardiovascular complications include effusive or constrictive pericarditis,cardiomyopathy,valvular heart disease,and coronary/vascular disease.These are pathophysiologically distinct disease entities whose prevalence varies depending on the timing and extent of radiation exposure to the heart and great vessels.Although refinements in RT dosimetry and shielding will inevitably limit future cases of RICVD,the increasing number of long-term cancer survivors,including those treated with older higher-dose RT regimens,will ensure a steady flow of afflicted patients for the foreseeable future.Thus,there is a pressing need for enhanced understanding of the disease mechanisms,and improved detection methods and treatment strategies.Newly characterized mechanisms responsible for the establishment of chronic fibrosis,such as oxidative stress,inflammation and epigenetic modifications,are discussed and linked to potential treatments currently under study.Novel imaging modalities may serve as powerful screening tools in RICVD,and recent research and expert opinion advocating their use is introduced.Data arguing for the aggressive use of percutaneous interventions,such as transcutaneous valve replacement and drug-eluting stents,are examined and considered in the context of prior therapeutic approaches.RICVD and its treatment options are the subject of a rich and dynamic body of research,and patients who are at risk or suffering from this disease will benefit from the care of physicians with specialty expertise in the emerging field of cardiooncology. | Jason R Cuomo Gyanendra K Sharma Preston D Conger Neal L Weintraub | 2016 | World Journal of Cardiology2016，8，9： | 17 |
| 2 | Differences in lipid composition of Doxorubicin-sensitive and resistant P388 cell显示文摘 | Ramu A Glaubiger D Weintraub H | 1984 | Cancer Treat Rep1984，68，： | 2 |
| 3 | Frequency and Correlates of Co - morbid Psychosis and Depressionin Parkinson' s Disease 显示文摘 | Weintraub D Morales KH Duda JE | 2006 | Parkinsonism Relat Disord2006，12，7： | 1 |
| 4 | Psychosis in Parkinson's disease without dementia:common and comorbid with other non- motor symptoms显示文摘 | Lee A H Weintraub D | 2012 | Mov Disord2012，27，7： | 1 |
| 5 | Effect of age on geriatric depression scale performance in Parkinson's disease显示文摘 | Weintraub D Saboe K Stern MB | 2007 | Mov Disord2007，22，： | 1 |
| 6 | Decompressive craniectomy inpediatric traumatic brain injury:a review of the literature显示文摘 | Weintraub D Williams BJ Jane J Jr | 2012 | Neu-roRehabilitation2012，30，3： | 1 |
| 7 | Comparison and predictors of rash associated with 15 antiepileptic drugs显示文摘 | Arif H Buchsbaum R Weintraub D | 2007 | Neurology2007，68，20： | 1 |
| 8 | Oxidative modifications and aggregation of Cu, Zn-superoxide dismutase associated with Alzheimer and Parkinsen diseases 显示文摘 | Choi J Rees H D Weintraub S T | 2005 | J Biol Chem2005，，11： | 1 |
| 9 | Rivastigmine in alzhe- imer's disease and Parkinson's disease dementia An ADAS-Cog factor analysis显示文摘 | Weintraub D Somogyi M Meng X | 2011 | American journal of Alzheimer''s disease and other dementias2011，26，6： | 1 |
| 10 | Novel insights into the molecular mechanisms of human thyrotropin action:structural,physiological,and therapeutic implications for the glycoprotein hormone family显示文摘 | Grossmann M Weintraub B D Szkudlinski M W | 1997 | Endocrine Reviews1997，18，4： | 1 |
| 11 | The movement disorder society evidence-based medicine review update:treatments for the non-motor symptoms of Parkinson's disease显示文摘 | Seppi K Weintraub D Coelho M | 2011 | Mov Disord2011，26，3： | 1 |
| 12 | Parkinson's disease-Par 3: Neuropsyehiatrie symptoms 显示文摘 | Weintraub D Comella CI Horn S | 2008 | Am J Manag Care2008，14，2： | 1 |
| 13 | The Movement Disorder Society Evi- dence-Based Medicine Review Update:Treatments for the non- motor symptoms of Parkinson' s disease 显示文摘 | Seppi K Weintraub D | 2011 | Mov Disord2011，26，3： | 1 |
| 14 | Patient-reported cognitive side effects of antiepileptic drugs:predictors and comparison of all commonly used antiepileptic drugs显示文摘 | Arif H Buchsbaum R Weintraub D | 2009 | Epilepsy Behay2009，14，1： | 1 |
| 15 | Effect of Antiepileptic Drug Comedication on Lamotrigine Clearance 显示文摘 | Weintraub D Buchsbaum R Resor SR | 2005 | Arch Neurol2005，62，9： | 1 |
| 16 | Antidepressant studies in Parkinson's disease : a review and meta-analysis 显示文摘 | Weintraub D Morales KH Moberg PJ | 2005 | Mov Disord2005，20，9： | 1 |
| 17 | Comparison and predictors of fash associated with 15 antiepileptic drugs 显示文摘 | ARIF H BUCHSBAUM R WEINTRAUB D | 2007 | Neurology2007，68，20： | 1 |
| 18 | Rationale and design of the randomized,multicenter,cilostaml for Restenosis (CREST) trial显示文摘 | Douglas JS Weintraub WS Holmes D | 2003 | Clin Cardiol2003，26，： | 1 |
| 19 | Parkinson' s disease: the quintes sential neuropsychiatric disorder 显示文摘 | Weintraub D Burn DJ | 2011 | Mov Disord2011，26，6： | 1 |
| 20 | Psychiatric issues in cognitive impairment显示文摘 | Aarsland D Taylor JP Weintraub D | 2014 | Mov Disord2014，29，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员